Cargando…
Corneal Alterations during Combined Therapy with Cyclodextrin/Allopregnanolone and Miglustat in a Knock-Out Mouse Model of NPC1 Disease
BACKGROUND: Niemann Pick disease type C1 is a neurodegenerative disease caused by mutations in the NPC1 gene, which result in accumulation of unesterified cholesterol and glycosphingolipids in the endosomal-lysosomal system as well as limiting membranes. We have previously shown the corneal involvem...
Autores principales: | Hovakimyan, Marine, Petersen, Jana, Maass, Fabian, Reichard, Maria, Witt, Martin, Lukas, Jan, Stachs, Oliver, Guthoff, Rudolf, Rolfs, Arndt, Wree, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232193/ https://www.ncbi.nlm.nih.gov/pubmed/22163015 http://dx.doi.org/10.1371/journal.pone.0028418 |
Ejemplares similares
-
A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1
por: Neßlauer, Anna-Maria, et al.
Publicado: (2019) -
Olfactory Deficits in Niemann-Pick Type C1 (NPC1) Disease
por: Hovakimyan, Marina, et al.
Publicado: (2013) -
Collagen Cross-Linking: Current Status and Future Directions
por: Hovakimyan, Marine, et al.
Publicado: (2012) -
Organ Weights in NPC1 Mutant Mice Partly Normalized by Various Pharmacological Treatment Approaches
por: Antipova, Veronica, et al.
Publicado: (2022) -
Miglustat Reverts the Impairment of Synaptic Plasticity in a Mouse Model of NPC Disease
por: D'Arcangelo, G., et al.
Publicado: (2016)